Abstract:Accurate diagnosis of the initial phase of Alzheimer's disease (AD) is essential and crucial. The objective of this research was to employ efficient biomarkers for the diagnostic analysis and classification of AD based on combining structural MRI (sMRI) and resting-state functional MRI (rs-fMRI). So far, several anatomical MRI imaging markers for AD diagnosis have been identified. The use of cortical and subcortical volumes, the hippocampus, and amygdala volume, as well as genetic patterns, has proven to be beneficial in distinguishing patients with AD from the healthy population. The fMRI time series data have the potential for specific numerical information as well as dynamic temporal information. Voxel and graphical analyses have gained popularity for analyzing neurodegenerative diseases, such as Alzheimer's and its prodromal phase, mild cognitive impairment (MCI). So far, these approaches have been utilized separately for the diagnosis of AD. In recent studies, the classification of cases of MCI into those that are not converted for a certain period as stable MCI (MCIs) and those that converted to AD as MCIc has been less commonly reported with inconsistent results. In this study, we verified and validated the potency of a proposed diagnostic framework to identify AD and differentiate MCIs from MCIc by utilizing the efficient biomarkers obtained from sMRI, along with functional brain networks of the frequency range .01-.027 at the resting state and the voxel-based features. The latter mainly included default mode networks (amplitude of low-frequency fluctuation [ALFF], fractional ALFF [ALFF], and regional homogeneity [ReHo]), degree centrality (DC), and salience networks (SN). Pearson's correlation coefficient for measuring fMRI functional networks has proven to be an efficient means for disease diagnosis. We applied the graph theory to calculate nodal features (nodal degree [ND], nodal path length [NL], and between centrality [BC]) as a graphical feature and analyzed the connectivity link between different brain regions. We extracted three-dimensional (3D) patterns to calculate regional coherence and then implement a univariate statistical t-test to access a 3D mask that preserves voxels showing significant changes. Similarly, from sMRI, we calculated the hippocampal subfield and amygdala nuclei volume using Freesurfer (version 6). Finally, we implemented and compared the different feature selection algorithms to integrate the structural features, brain networks, and voxel features to optimize the diagnostic identifications of AD using support vector machine (SVM) classifiers. We also compared the performance of SVM with Random Forest (RF) classifiers. The obtained results demonstrated the potency of our framework, wherein a combination of the hippocampal subfield, the amygdala volume, and brain networks with multiple measures of rs-fMRI could significantly enhance the accuracy of other approaches in diagnosing AD. The accuracy obtained by the proposed method was reported for binary classification. More importantly, the classification results of the less commonly reported MCIs vs. MCIc improved significantly. However, this research involved only the AD Neuroimaging Initiative (ADNI) cohort to focus on the diagnosis of AD advancement by integrating sMRI and fMRI. Hence, the study's primary disadvantage is its small sample size. In this case, the dataset we utilized did not fully reflect the whole population. As a result, we cannot guarantee that our findings will be applicable to other populations.

Multimodal active subspace analysis for computing assessment oriented subspaces from neuroimaging data

Learning Active Multimodal Subspaces in the Brain

Subspace Regularized Sparse Multitask Learning for Multiclass Neurodegenerative Disease Identification

Multimodal subspace independent vector analysis effectively captures the latent relationships between brain structure and function

Supervised multiblock sparse multivariable analysis with application to multimodal brain imaging genetics

Identifying Alzheimer's Disease-Related Brain Regions from Multi-Modality Neuroimaging Data Using Sparse Composite Linear Discrimination Analysis.

Multimodal Predictive Modeling: Scalable Imaging Informed Approaches to Predict Future Brain Health

Classification and Graphical Analysis of Alzheimer’s Disease and Its Prodromal Stage Using Multimodal Features From Structural, Diffusion, and Functional Neuroimaging Data and the APOE Genotype

Developing univariate neurodegeneration biomarkers with low-rank and sparse subspace decomposition

Sparse Discriminative Feature Selection for Multi-class Alzheimer’s Disease Classification

Alzheimer's Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural MRI

Biomarker Investigation using Multiple Brain Measures from MRI through XAI in Alzheimer's Disease Classification

Self-supervised multimodal neuroimaging yields predictive representations for a spectrum of Alzheimer's phenotypes

Identifying disease sensitive and quantitative trait-relevant biomarkers from multidimensional heterogeneous imaging genetics data via sparse multimodal multitask learning.

A Multimodal Learning Machine Framework for Alzheimer’s Disease Diagnosis Based on Neuropsychological and Neuroimaging Data

Enhancing Autism Spectrum Disorder identification in multi-site MRI imaging: A multi-head cross-attention and multi-context approach for addressing variability in un-harmonized data

Multi-modal Spatial-modality Attentive Fusion for Studying Neuropsychiatric Disorders

Ensemble Sparse Classification of Alzheimer's Disease

Multiple Kernel Learning and Automatic Subspace Relevance Determination for High-dimensional Neuroimaging Data

Region-of-Interest Based Sparse Feature Learning Method for Alzheimer's Disease Identification

Sparse Inverse Covariance Analysis Of Human Brain For Alzheimer'S Disease Study